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Summary
Derivative 22 (der[22]) syndrome is a rare disorder as-
sociated with multiple congenital anomalies, including
profound mental retardation, preauricular skin tags or
pits, and conotruncal heart defects. It can occur in off-
spring of carriers of the constitutional t(11;22)(q23;q11)
translocation, owing to a 3:1 meiotic malsegregation
event resulting in partial trisomy of chromosomes 11
and 22. The trisomic region on chromosome 22 overlaps
the region hemizygously deleted in another congenital
anomaly disorder, velo-cardio-facial syndrome/Di-
George syndrome (VCFS/DGS). Most patients with
VCFS/DGS have a similar 3-Mb deletion, whereas some
have a nested distal deletion endpoint resulting in a 1.5-
Mb deletion, and a few rare patients have unique de-
letions. To define the interval on 22q11 containing the
t(11;22) breakpoint, haplotype analysis and FISH map-
ping were performed for five patients with der(22) syn-
drome. Analysis of all the patients was consistent with
3:1 meiotic malsegregation in the t(11;22) carrier parent.
FISH-mapping studies showed that the t(11;22) break-
point occurred in the same interval as the 1.5-Mb distal
deletion breakpoint for VCFS. The deletion breakpoint
of one VCFS patient with an unbalanced t(18;22) trans-
location also occurred in the same region. Hamster-hu-
man somatic hybrid cell lines from a patient with der(22)
syndrome and a patient with VCFS showed that the
breakpoints occurred in an interval containing low-copy
repeats, distal to RANBP1 and proximal to ZNF74. The
presence of low-copy repetitive sequences may confer
susceptibility to chromosome rearrangements. A 1.5-Mb
region of overlap on 22q11 in both syndromes suggests
the presence of dosage-dependent genes in this interval.
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Introduction
The constitutional t(11;22)(q23;q11) balanced translo-
cation is the most common recurrent non-Robertsonian
translocation in humans (Fraccaro et al. 1980; Zackai
and Emanuel 1980). Although individuals who carry this
translocation are normal, their offspring are susceptible
to derivative 22 (der[22]) syndrome, owing to a 3:1 mei-
otic nondisjunction event. Affected offspring carry a
supernumerary der(22) chromosome, 22pter-22q11::
11q23-11qter (Fraccaro et al. 1980; Zackai and Eman-
uel 1980). The clinical features of patients with der(22)
syndrome include severe mental retardation, malformed
ears, preauricular skin tags and/or pits, cleft palate, mi-
croretrognathia, and conotruncal heart defects (predom-
inantly, atrial septal defect) (Zackai and Emanuel 1980;
Lin et al. 1986). A second disorder of increased gene
dosage on chromosome 22q11 is termed “cat-eye syn-
drome” (CES; MIM 115470). Patients with CES have a
partial tetrasomy of chromosome 22 that is due to the
presence of a bisatellited supernumerary chromosome
with an inverted duplication of 22pter-22q11 (Schinzel
et al. 1981; Mears et al. 1994, 1995). The duplication
breakpoints of some patients with CES overlap with the
region that is trisomic in patients with der(22) syndrome
(McTaggart et al. 1998). The phenotypic spectrum of
patients with der(22) syndrome overlaps with that of
CES but is associated with more-severe mental retar-
dation, presumably owing to the effects of trisomy
22q11.2 and 11q23-qter (Guanti 1981; Schinzel et al.
1981; Reiss et al. 1985; Van Hove et al. 1992; Knoll et
al. 1995).
In addition to disorders that occur as a result of in-
creased gene dosage, decreased gene dosage on 22q11
is responsible for the etiology of velo-cardio-facial syn-
drome (VCFS; MIM 192430) (Shprintzen et al. 1978;
Driscoll et al. 1992a; Scambler et al. 1992) and Di-
George syndrome (DGS; MIM 188400) (Driscoll et al.
1992b; Scambler et al. 1992). VCFS is characterized by
velopharyngeal insufficiency, mild facial dysmorphology,
submucous cleft palate, conotruncal heart defects, and
learning disabilities (Shprintzen et al. 1978). DGS is phe-
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notypically related to VCFS, and patients with DGS
have, in addition to the clinical findings of VCFS, thymic
aplasia or hypoplasia and severe hypocalcemia (Di-
George 1965). Most patients with VCFS and DGS have
overlapping hemizygous deletions of 22q11, suggesting
that haploinsufficiency of the same genes may be re-
sponsible for the etiology of these diseases (Driscoll et
al. 1992a, 1992b; Scambler et al. 1992). Haplotype anal-
ysis performed by use of 15 consecutive genetic markers
on 22q11 showed that 83% of the patients with VCFS
had a 22q11 deletion (Carlson et al. 1997); of these
patients, 90% had a similar 3-Mb deletion. A second
class of deletions share the 3-Mb proximal breakpoint
but have a nested distal deletion endpoint resulting in a
1.5-Mb deletion. Although rare, a few patients with
VCFS/DGS have unique rearrangements or deletions
(Budarf et al. 1995; Kurahashi et al. 1996; Levy et al.
1995; O’Donnell et al. 1997). The 3-Mb region that is
deleted in patients with VCFS/DGS overlaps with the
region that is duplicated in some patients with CES
(Mears et al. 1994, 1995; McTaggart et al. 1998) and
in patients with der(22) syndrome (Carey et al. 1990;
Budarf et al. 1996), suggesting that dosage-sensitive
genes may reside in this interval.
To precisely define the interval containing the t(11;22)
breakpoints on 22q11, we performed haplotype analysis
and FISH-mapping studies of patients with der(22) syn-
drome. We found that the t(11;22) breakpoint occurs
in the same interval as the 1.5-Mb distal deletion
breakpoint for VCFS/DGS. These results suggest that
there are sequences in this interval that are prone to
rearrangement.
Subjects and Methods
Clinical Diagnosis and Preparation of DNA from
Patients with Der(22) Syndrome and VCFS
The patients with der(22) syndrome who were ascer-
tained for this study met the diagnostic criteria for the
disorder, including most or all of the following clinical
features: moderate to profound mental retardation,
characteristic mild facial dysmorphology, preauricular
skin tags or pits, congenital heart disease, genitourinary
defects, renal defects, and the presence of the der(22)
chromosome. BM85 is a male of Arabic descent and was
examined most recently at 13 years of age. He was se-
verely retarded, nonverbal, and aggressive and had
widely spaced nipples, with an asymmetric chest, a nor-
mal heart, abnormal genitalia, and mild facial dysmor-
phology. Patient BM97, a black American, died shortly
after birth. Her physical examination showed prominent
bilateral preauricular fistula, typical facial dysmorphol-
ogy, large anterior cataract on the right eye, clinodactyly
and brachydactyly, malposition of the anus, with a tag,
and widely spaced nipples. BM113, the dizygotic twin
of BM97, was normal. BM317, a patient with der(22)
syndrome, is of Greek descent and was examined at 17
mo of age. Examination showed a cleft palate, microgna-
thia, unilateral preauricular tags, and hip dysplasia. Cell
lines were obtained for the two patients with der(22)
syndrome, GM06228 and GM04370, from the NIGMS
cell repository (Coriell Cell Repositories). The diagnostic
criteria for VCFS have been described elsewhere (Carl-
son et al. 1997). Genomic DNA was prepared from 5
ml peripheral venous blood, by use of the Puregene pro-
tocol (Gentra). The blood samples were collected with
the patients’ informed consent (program approved by
the Internal Review Board of the Albert Einstein College
of Medicine).
Genotype Analysis
Each sample containing genomic DNA (100 ng) was
genotyped separately with 15 consecutive genetic
markers: D22S420, D22S427, D22S1638, D22S941,
D22S1648, D22S944N, D22S1623, D22S264,
D22S311, D22S1709, D22S306, D22S308, D22S425,
D22S303, and D22S257 (Carlson et al. 1997). One of
two primers was radiolabeled, and a PCR product was
amplified under standard conditions (Morrow et al.
1995). The radiolabeled PCR products were separated
on 6% acrylamide denaturing sequencing gels, and a set
of individuals with known allele sizes was used as a
sizing control. The autoradiograms were exposed for 24
h, and films were analyzed manually. Mendelian inher-
itance within each family was verified.
FISH Mapping
The three LL22NC03 cosmids (Roswell Park Cancer
Institute) that were used for FISH mapping were 62C4
(22q13), 84F7 (22q11), and 48C12 (22q11). The DNA
(50 mg) from each cosmid was prepared by use of the
Qiagen midi-preparation kit. The cosmid DNAs (1 mg/
5 slides) were labeled separately by nick translation with
either biotin-16 dUTP (Gibco BRL BioNick Labeling
System), for 84F7 and 48C12, or digoxigenin-11-dUTP
(Boehringer Mannheim Nick Translation Kit), for 62C4.
The repetitive sequences on the cosmids were blocked
by prehybridization with 50 mg Cot-1 DNA (Gibco
BRL). Metaphase chromosomes were prepared as de-
scribed elsewhere (Luan et al. 1997). Detection of nick-
translated probes was performed as described in Oncor’s
“In Situ Hybridization Manual.” In brief, for detection
of biotinylated probes, successive incubations with fluo-
rescein-labeled avidin and anti-avidin antibodies were
performed. For detection of digoxigenin-labeled probes,
successive incubations with rhodamine-labeled anti-
digoxigenin, rabbit anti-sheep antibodies, and rhoda-
mine-labeled anti-rabbit antibodies were performed. The
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chromosomes were stained with propidium iodide (sin-
gle-probe detection) or DAPI (dual-color detection).
Generation of Human-Hamster Somatic Hybrid
Cell Lines
Somatic hybrid cell lines were developed by fusion of
Epstein-Barr–transformed lymphoblastoid cell lines
from patient BM97, as described elsewhere (Carlson et
al. 1997). Somatic hybrid cell lines were generated pre-
viously for patient BM8, who had VCFS (Carlson et al.
1997). In brief, the lymphoblastoid cells from patient
BM97 were fused, by use of polyethylene glycol,
to hypoxanthine phosphoribosyltransferase–deficient
CHTG49 Chinese hamster-ovary fibroblasts. After se-
lection in HAT medium (hypoxanthine, aminopterin,
and thymidine; Gibco/BRL), individual clones were
tested, by PCR, for retention of chromosome 22. The
positive clones were expanded and subjected to genotype
analysis, to confirm the integrity of each copy of chro-
mosome 22, as well as to identify the der(22) chromo-
some. Clones that contained either the normal chro-
mosome 22 or the der(22) chromosome were expanded
further, and DNA was extracted (Puregene Kit, Gentra).
Results
Haplotype Analysis
To define the region that contains the t(11;22) break-
point, we performed haplotype analysis by using 15 or-
dered genetic markers that span a 5-Mb region on 22q11
(Carlson et al. 1997). The DNAs from five patients,
BM85, BM97, BM317, GM06228, and GM04370, and
their family members, when available, were genotyped.
Haplotypes were deduced by comparison of the geno-
types of the patients with der(22) syndrome with those
of their parents (fig. 1). The presence of three alleles of
different sizes for a given genetic marker is informative
that the locus is trisomic. Inheritance of one allele from
a heterozygous t(11;22) carrier parent and a different-
sized allele from the other parent is informative for a
disomic locus.
Three different alleles (6, 3, and 5) were detected for
D22S420 in der(22) syndrome patient GM06228 (fig.1).
The patient had inherited alleles 3 and 5 from her
t(11;22) carrier mother and allele 6 from her father (not
available for analysis). For the next distal marker,
D22S427, the patient had inherited alleles 1 and 4, as
had her mother. This marker was uninformative. Mark-
ers D22S427–D22S264 were uninformative for this pa-
tient. For the next distal marker, D22S311, the mother
had alleles 4 and 1. The patient must inherit both alleles
to be considered trisomic at this locus. Since the child
was homozygous for allele 4, she must have inherited
only one copy of D22S311 from her mother. The
t(11;22) breakpoint must have occurred proximal to this
marker. Marker D22S1709 was also disomic. The
t(11;22) breakpoint occurred between D22S420 and
D22S311.
The haplotypes for three other patients with der(22)
syndrome—GM04370, BM317, and BM97—are shown
in figure 1. For patient GM04370, the t(11;22) break-
point occurred between D22S427 and D22S264. For
BM317, the breakpoint was between D22S941 and
D22S425, and for BM97 the breakpoint was between
D22S1648 and D22S264. BM113, the dizygotic twin
sister of BM97, was found to be a t(11;22) carrier, as
deduced by means of haplotype analysis (fig. 1). Hap-
lotype analysis could not be performed for der(22) syn-
drome patient BM85, because the DNA from his parents
was not available for analysis. For BM85, three
different-sized alleles were present for D22S427 and
D22S1638, and the rest of the markers had one or two
different-sized alleles (data not shown).
To more precisely define the t(11;22) breakpoint in
each patient and to determine whether it lies in the same
interval, we performed the FISH-mapping studies de-
scribed in the next section (figs. 2 and 3). The probes
used for FISH were derived from cosmids 84F7 and
48C12. Cosmid 84F7 is distal to D22S1623, and cosmid
48C12 contains the D22S264 marker (fig. 4). Because
the breakpoints were found to occur in the interval
flanked by the two cosmids, which is betweenD22S1623
and D22S264, their locations were incorporated in-
to figure 1. The interval flanked by D22S1623 and
D22S264 is the same interval that contains the 1.5-Mb
distal deletion breakpoint in VCFS patients BM8, BM13,
BM14, and BM15, as was determined by haplotype
analysis (Carlson et al. 1997). The results from haplo-
type analysis of VCFS patient BM58, who carries a
t(18;22) unbalanced translocation, are shown in figure
1. The unbalanced-translocation breakpoint also oc-
curred between D22S1623 and D22S264 (fig. 1).
FISH Mapping
FISH mapping was performed to more precisely map
the t(11;22) breakpoint in the five patients described
above. Representative FISH-mapping results, with two
cosmid probes, 84F7 and 48C12, on the metaphase
chromosomes from lymphoblastoid cell lines prepared
from BM97 and her t(11;22) carrier mother, BM114,
are shown in figure 2. The probes for FISH mapping
were derived from two cosmids that map to the 22q11
region near D22S1623 and D22S264. Cosmid 84F7
maps distal to D22S1623, and cosmid 48C12 contains
D22S264 (fig. 4). The two cosmid probes, when hy-
bridized separately, produce one set of signals on each
of the two normal copies of chromosome 22 and are
deleted in patients with VCFS who have the common 3-
Figure 1 Haplotype analysis of patients with der(22) syndrome (gray-shaded symbols) and patients with VCFS (blackened symbols). VCFS patient BM58 had a t(18;22) unbalanced translocation.
The 15 genetic markers that span the 22q11 region are ordered from the top, most centromeric marker, D22S420, to the bottom, most telomeric marker, D22S257 (Carlson et al. 1997). The bars
represent the chromosome of origin, as deduced from the genotype of the patient. A bracket indicates a region containing uninformative markers for the t(11;22) or VCFS deletion breakpoint interval.
The chromosome breakpoints in each patient occurred between D22S1623 and D22S264, as determined by FISH mapping (figs. 2 and 3).
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Figure 2 Results of FISH-mapping studies of BM97 and BM114. Metaphase chromosomes from BM97 (A and B) and her t(11;22) carrier
mother, BM114 (C and D), were hybridized with fluorescent probes from cosmids 84F7 (A, C, and D) and 48C12 (B and D). Cosmid 84F7
maps proximal to cosmid 48C12 (see fig. 4).
Mb deletion (data not shown). For BM97, 84F7 hy-
bridized to three different loci, as shown in figure 2A.
Hybridization was detected on the der(22) chromosome
and on each normal copy of chromosome 22. The more
telomeric 48C12 probe hybridized to two loci, one on
each normal chromosome 22 (fig. 2B). These results
show that, for BM97, the cosmid probes flank the
t(11;22) breakpoint. The same result was obtained for
der(22) syndrome patients BM85, BM317, GM04370,
and GM06228 (data not shown). For BM114, the
t(11;22) carrier mother of BM97, two sets of signals
were detected with 84F7 (fig. 2C). Hybridization oc-
curred on the der(22) chromosome and on the normal
copy of chromosome 22. When the two probes, 84F7
and 48C12, were mixed and hybridized to chromosomes
from BM114, three signals were detected—one on the
der(11) chromosome, one on the der(22) chromosome,
and one on the normal copy of chromosome 22 (fig.
2D).
Similar FISH-mapping studies were performed on
BM58, the patient with VCFS who carries a t(18;22)
unbalanced translocation. A cosmid 62C4 probe that
maps to 22q13 was used to identify the der(18) chro-
mosome (fig. 3). Hybridization of 62C4 to normal meta-
phase chromosomes detects signals only on chromosome
22q13 (data not shown). In the metaphase spread from
BM58, 62C4 hybridized (rhodamine detection) to the
normal copy of chromosome 22 and to the larger der(18)
chromosome (fig. 3A). Hybridization was detected, by
use of 84F7 (fluorescein detection), on the normal copy
of chromosome 22 but not on the der(18) chromosome
(fig. 3A). Hybridization was detected, for 48C12 (fluo-
rescein detection), on the larger der(18) chromosome
and on the normal chromosome 22 (fig. 3B). These re-
sults indicate that the deletion occurred between cosmids
84F7 and 48C12.
Representative FISH-mapping results are shown for
patient BM15 (fig. 3), a patient with VCFS and the 1.5-
Mb deletion (Morrow et al. 1995). The 22q13 62C4
probe hybridized to both copies of chromosome 22, as
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Figure 3 Results of FISH-mapping studies of two patients, BM58 and BM15, with VCFS. Metaphase chromosomes from the t(18;22)
unbalanced translocations of VCFS patient BM58 (A and B) and unrelated VCFS patient BM15 (C and D), who has the 1.5-Mb deletion, were
hybridized with probes from cosmids 84F7 and 62C4 (fluorescein and rhodamine, respectively; A and C) or cosmids 48C12 and 62C4 (fluorescein
and rhodamine, respectively; B and D). Cosmid 62C4 maps to 22q13, near the telomere, and was used as a probe to detect chromosome 22.
was observed by the presence of two sets of signals (rho-
damine detection; fig. 3C). Only one set of signals was
detected for 84F7, on one of the two chromosomes 22
(fluorescein detection; fig. 3C). Two hybridization sig-
nals were detected, by use of 48C12, on both copies of
chromosome 22 (fig. 3D), indicating that the distal de-
letion breakpoint for BM15 occurred between cosmids
84F7 and 48C12, in the same region as that in BM58.
Similar results were obtained for patients AP1037 and
GM05401 (data not shown). The FISH results showed
that the t(11;22) translocation breakpoint and the VCFS
1.5-Mb distal deletion breakpoint occurred in an iden-
tical interval flanked by 84F7 and 48C12 (fig. 4). The
genetic interval containing the breakpoints is flanked by
D22S1623 and D22S264 (fig. 1).
Physical Map of the Breakpoint Interval
To define the 5-Mb 22q11 region, a physical map was
constructed by assembling of overlapping sets of YACs,
termed “YAC contigs” (Collins et al. 1995; Morrow et
al. 1995). A gap in the physical map, owing to an un-
derrepresentation of YAC clones, occurred between
markers D22S933 and D22S264 (Collins et al. 1995;
Morrow et al. 1995) (fig. 4). A high-resolution physical
map of a 1,080-kb region in 22q11, consisting of over-
lapping cosmid clones, was constructed (Carlson et al.
1997). The distal end of the cosmid contig was demar-
cated by the sequence-tagged site (STS) D22S933, pres-
ent in P1 artificial chromosome (PAC) 296F16 (Carlson
et al. 1997). To extend the physical map in a telomeric
direction, we developed STS markers from the genomic
sequence of cosmid 68F10 and PAC 201M18 (University
of Oklahoma; fig. 4). The STSs were used as probes to
obtain additional clones for genomic walking. Genomic
walking was used to extend the map in a centromeric
direction from the genetic marker D22S264. Positive
bacterial artificial chromosome (BAC), PAC, and cosmid
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Figure 4 High-resolution physical map of the chromosome breakpoint interval on 22q11. The PCR markers used to construct the map
are indicated above the line representing chromosome 22q11. The orientation of the map is centromere (left) to telomere (right). The genetic
markers (circles), anonymous genomic markers (squares), and genes or expressed sequences (triangles) are shown. STS markers were developed
from the genomic sequences of cosmid 68F10 and PAC 201M18 (University of Oklahoma). We developed a set of STS markers that spanned
this region from the sequence. The STSs were used as probes, to obtain additional clones for genomic walking. The STSs derived from the ends
of clones are denoted by “X.” The gray-shaded symbols indicate low-copy repeats that are repeated elsewhere on 22q11. The bracket under
markers D22S663 and D22S934 indicates that these markers could not be ordered unambiguously, with respect to each other. The bacterial
clones represented below the line consist of BACs (“BAC” preceding the address), PACs (“PAC” preceding the address), and cosmids (nothing
preceding the address). The cosmid clones used for FISH mapping are outlined.
clones were confirmed by PCR analysis. To increase the
density of markers on the physical map, we sequenced
the insert ends of bacterial clones and generated new
PCR markers (fig. 4). The 84F7 and 48C12 cosmid
clones used for FISH mapping were integrated into
the map. Cosmid 84F7 is distal to genetic marker
D22S1623, and cosmid 48C12 contains genetic marker
D22S264, as shown in figure 4. The T10 (Halford et al.
1993b), RANBP1 (Bischoff et al. 1995; Puech et al.
1997), HTF9-C (Puech et al. 1997; Di Matteo et al.
1998), ZNF74 (Aubry et al. 1993), and HCF2 (Herzog
et al. 1991) genes were integrated into the map (fig.
4). Of interest, one of the expressed-sequence tags,
zu06b07.s, was homologous to the phosphatidylinositol
4–kinase gene, indicating that this gene may be localized
to this interval (GenBank accession number AF012872).
Low-copy–repeat clusters span the 22q11 region (Hal-
ford et al. 1993a; Collins et al. 1997; L. Edelmann, un-
published data). One such low-copy repeat can be de-
tected by interphase FISH, by use of a probe derived
from a cosmid termed “sc11.1” (Lindsay et al. 1993).
The sc11.1 cosmid probe produces two signals, sc11.1a
(proximal) and sc11.1b (distal), that are 1–2 Mb apart
on each normal copy of chromosome 22 (Lindsay et al.
1993). Both signals are deleted in patients with the 1.5-
Mb or the 3-Mb VCFS deletion (Lindsay et al. 1995).
The sc11.1a locus maps just distal to the common prox-
imal deletion breakpoint that occurs in patients with
VCFS (Carlson et al. 1997). The sc11.1b locus has been
integrated into the physical map illustrated in figure 4.
The sc11.1b locus maps telomeric to 201M18I and con-
tains markers 95D4T7–444P24SP6 (fig. 4).
Markers 518B9T7, 361L4SP6, 26K4SP6, and
334O10SP6 are members of the 22q11 low-copy–repeat
clusters termed the “LCR22s,” which map to the prox-
imal and distal deletion breakpoints in patients with
VCFS/DGS who have the common 3-Mb deletion (Edel-
mann et al., in press). A set of genes or pseudogenes,
including GGT (gamma-glutamyl transpeptidase gene)
and BCRL (breakpoint cluster region–like gene) (Collins
et al. 1997) compose each of the eight known LCR22s
(Collins et al. 1997; L. Edelmann, unpublished data).
To extend the physical map from the flanking repeat
markers, it was necessary to identify clones that are an-
chored to this interval and that are positive for both
markers 201M18I and ZNF74. None of the clones that
were identified spanned this interval. To complete the
physical map, it was necessary to identify BAC and PAC
clones that are anchored to the physical map and that
contain additional markers, from within the repeat, that
can serve as additional anchor points for the assigning
of clones to this specific repeat and not to the other eight
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Figure 5 PCR analysis of chromosome 22q11 from hamster-human somatic hybrid cell lines. The deleted copy of chromosome 22q11 is
shown for BM8, a VCFS patient. The der(22) chromosome and one intact chromosome from BM97 is also shown. The PCR markers that
represent the 3-Mb chromosome 22q11 region are shown, ordered from the centromere (left) to the telomere (right). PCR markers
159O3T7–120A5T7 map proximal to the VCFS 3-Mb common proximal breakpoint (Edelmann et al., in press). Markers 444P24SP6, 108-2,
and 95D4T7 compose the sc11.1a and sc11.1b loci (Edelmann et al., in press). ADU6 and ADU1 are 10,250 bp apart (Genbank AC000095)
and contain the proximal breakpoint in BM8 and the ADU breakpoint. Markers GP1BB-b, TBX-a, COS89, COMT-a, 201M15H, and 201M15I
were generated from the genomic sequence of 22q11 (University of Oklahoma). Markers C84–D22S311 are shown in figure 4. Markers 18F11T7
and 107D7T3 (D22S1709) and markers 245G21SP6–287O7T7 map proximal and distal, respectively, to the VCFS 3-Mb distal deletion
breakpoint interval (Edelmann et al., in press). The 1-kb ladder size standard (NE Biolabs) flanks the PCR products. Arrow A indicates the
proximal breakpoint in BM8, and arrow B indicates the t(11;22) breakpoint and the distal deletion breakpoint interval in BM8. The 2% agarose
gel was stained with SYBR green (Molecular Probes).
copies of LCR22s. The BAC and PAC libraries were
underrepresented in this region. None of the cosmid
clones that were isolated could be anchored to this spe-
cific copy of the LCR22s. Because of the repetitive nature
of the markers in this interval, it has not yet been possible
to close the remaining gap in the map that contains the
repeat.
Somatic Cell–Hybrid Cell Analysis of the t(11;22)
Breakpoint on 22q11
The average spacing of the 15 genetic markers that
map to the 5-Mb 22q11 region is 300 kb. To more
precisely define the interval containing the t(11;22)
breakpoint on 22q11, we generated hamster-human so-
matic cell hybrids from BM97. The der(22) chromosome
was physically separated from the two normal copies of
chromosome 22 in separate cell lines. Template DNA
from the der(22) chromosome was examined by PCR
with the STS markers that were ordered on the physical
map (fig. 5). The t(11;22) breakpoint occurred between
the genes RANBP1 and ZNF74, distal to 201M18I.
The PCR markers distal to 201M18I and proximal to
ZNF74 were present in the DNA from the der(22)
chromosome. However, because they were repeated on
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22q11 in each copy of the LCR22s (L. Edelmann, un-
published data), they were not informative (fig. 5).
To determine whether patients with VCFS have a de-
letion breakpoint in the same region as the t(11;22)
breakpoint on 22q11, a similar analysis was performed
with the deleted copy of chromosome 22 from VCFS
patient BM8 and with a normal copy of chromosome
22 from BM97, as a control (fig. 5). The common prox-
imal breakpoint in patients with VCFS with the 1.5-Mb
or the 3-Mb deletion occurs between D22S427 and
D22S1638 (Carlson et al. 1997). Patient BM8 has a
unique nested proximal deletion breakpoint within 40
kb distal to genetic marker D22S1638 (Carlson et
al.1997). The breakpoint in BM8 is between markers
ADU6 and ADU1 (A in fig. 5). The distal deletion end-
point occurred between D22S1623 and D22S264 (Carl-
son et al. 1997). PCR analysis showed that the distal
deletion breakpoint in BM8 occurred in the same inter-
val as that for the t(11;22) breakpoint, between
201M18I and ZNF74 (B in fig. 5). Similarly, the repet-
itive markers were not informative by PCR; however,
interphase FISH studies with cosmid sc11.1 showed that
one locus, presumably the sc11.1b locus, was deleted
(Lindsay et al. 1995), indicating that the breakpoint in
BM8 occurs distal to the sc11.1b locus and proximal to
ZNF74.
Discussion
Mechanism of Rearrangements on 22q11
The 22q11 region is prone to rearrangements leading
to congenital anomaly disorders. CES, der(22) syn-
drome, and VCFS/DGS occur as a result of tetrasomy,
trisomy, and monosomy, respectively, of part of 22q11.
The human genome contains repetitive DNA sequences
that are categorized depending on their frequency of
occurrence and sequence composition. For example,Alu
elements are repeated several hundred thousand times,
and long interspersed repetitive elements are repeated
one order of magnitude less, throughout the genome
(Moyzis et al. 1989). Sequences that are repeated just a
few times in the genome, such as gene-family members,
are referred to as low-copy repeats. Low-copy–repeat
clusters of different sequence composition span the
22q11 region (Halford et al. 1993a; Lindsay et al. 1993;
Collins et al. 1997).
Most patients with VCFS/DGS have a similar 3-Mb
deletion. To understand the basis of the deletion, the
region surrounding the deletion breakpoints was defined
by construction of high-resolution physical maps. We
found that the proximal and distal breakpoints leading
to the common 3-Mb deletion occur in a low-copy–
repeat cluster, the LCR22s (L. Edelmann, unpublished
data). Both intrachromosomal rearrangements and un-
equal crossing over of misaligned chromosomes mediate
the common 3-Mb deletion (Baumer et al. 1998). It is
possible that the LCR22s mediate the meiotic homolo-
gous recombination events.
Approximately 7% of patients with VCFS have a
smaller 1.5-Mb deletion (Morrow et al. 1995; Carlson
et al. 1997). They share a common proximal breakpoint
with the patients with VCFS who have the 3-Mb deletion
but have a nested distal deletion breakpoint. In this
study, we showed by haplotype analysis, FISH, and so-
matic cell–hybrid analysis that the t(11;22) translocation
breakpoint occurs in the same interval as the 1.5-Mb
distal VCFS deletion breakpoint. We also showed that
LCR22 sequences map to the 1.5-Mb distal deletion
breakpoint interval. It has not yet been possible to com-
plete the map containing LCR22 sequences near the 1.5-
Mb distal deletion breakpoint, because the anchored
clones are not large enough to span the LCR22s. Because
LCR22 sequences are present in the interval, it is possible
that mechanisms of deletion that are similar to those for
the 3-Mb deletion may occur. Further physical-mapping
experiments and haplotype analysis of three-generation
families of patients with the 1.5-Mb deletion are nec-
essary to show whether the mechanism of the deletion
is the same as that for patients with the 3-Mb deletion.
Low-copy repeats have been implicated in rearrange-
ments associated with disorders that map to other chro-
mosomes, such as Charcot-Marie-Tooth disease type 1A
and hereditary neuropathy with liability to pressure pal-
sies. These disorders are peripheral neuropathies asso-
ciated with a duplication or deletion, respectively, of the
same region on chromosome 17p11.2-12 (Chance et al.
1994). Other chromosomal rearrangement disorders as-
sociated with low-copy repeats of varying sizes are Smith
Magenis syndrome on 17p11.2 (Chen et al. 1997),
Prader-Willi syndrome/Angelman syndrome on 15q11-
13 (Wandstrat et al. 1998), and Williams-Beuren syn-
drome on 7q11.23 (Perez Jurado et al. 1998). In most
cases, the mechanism of rearrangement is by homolo-
gous recombination between low-copy repeats, as pro-
posed for the 1.5-Mb and 3-Mb VCFS deletions.
The mechanism leading to the recurrent t(11;22)
translocation is not known. The 11q23 interval that har-
bors the t(11;22) translocation has not been defined at
the same resolution as for the 22q11 region. One pos-
sible reason why this translocation occurs recurrently in
the population is that there may be a subset of low-
copy–repeat sequences on 11q23 that are similar in com-
position to those on 22q11, and these sequences may
mediate the balanced translocation, by homologous re-
combination events.
Dosage-Sensitive Genes Map to 22q11
CES, der(22) syndrome, and VCFS/DGS are clinical
disorders associated with partial tetrasomy, trisomy, and
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monosomy, respectively, of part of chromosome 22. The
three disorders share a 1.5-Mb region of sequence over-
lap that is flanked by genetic markers D22S427 and
D22S264. Decreased gene dosage on 22q11 is associated
with craniofacial anomalies, conotruncal heart defects,
and learning disabilities. To determine whether increased
gene dosage in this region contributes to the etiology
of congenital anomalies, it is necessary to determine
whether there are specific defects in individual patients
that can be attributed to this interval.
The main clinical findings for patients with CES in-
clude mild or no mental retardation, deformed ears,
preauricular skin tags and/or pits, and conotruncal heart
defects (Guanti 1981). Two distinct CES-chromosome
duplication breakpoints in 22q11 have been defined
(McTaggart et al. 1998). The smaller, CES-I duplication
breakpoint occurs in the same region as the common
proximal breakpoint in patients with VCFS/DGS. There-
fore, patients with CES-I do not share sequence overlap
with patients with VCFS/DGS. The larger, CES-II du-
plication breakpoint occurs in the same region as the 3-
Mb distal deletion breakpoint (McTaggart et al. 1998).
Patients with CES-II share a 3-Mb region of overlap with
patients with VCFS/DGS. If increased gene dosage in the
3-Mb region is associated with physical anomalies, pa-
tients with CES-II should have these additional anom-
alies. Clinical analysis of a small set of patients with
CES-II showed that they are no more severely affected
than are patients with CES-I, suggesting that the genes
that contribute to CES are proximal to the CES-I break-
point (McTaggart et al. 1998). The levels of phenotypic
expression in patients with CES vary significantly, pre-
cluding the ability to precisely define chromosome sub-
regions that contribute to the physical anomalies of this
disorder (Mears et al. 1994; McTaggart et al. 1998).
The clinical features of CES overlap with those of
patients with der(22) syndrome (Reiss et al. 1985; Knoll
et al. 1995). In contrast to patients with CES, who have
no or mild mental retardation, patients with der(22) syn-
drome have profound mental retardation (Reiss et al.
1985). To determine the basis of der(22) syndrome, it
is necessary to identify the phenotypic contribution of
the 22q11 and the 11q23-qter regions. Clinical assess-
ment of anomalies in patients with rare 22q11 dupli-
cations suggests that trisomy 22q11 may contribute to
the anomalies of der(22) syndrome (Reiss et al. 1985;
Knoll et al. 1995; Lindsay et al. 1995; Prasher et al.
1995). However, the size of the duplications extend into
the 22q12 or 22q13 regions (Reiss et al. 1985; Knoll et
al. 1995; Lindsay et al. 1995; Prasher et al. 1995). It is
possible that the 11q23-qter region may contribute to
the severity of mental retardation in patients with
der(22) syndrome (Van Hove et al. 1992; Smeets et al.
1997).
We recently have identified a child with developmental
delay that has a duplication of the same 3-Mb region
on 22q11 that is deleted in patients with VCFS/DGS and
that is duplicated in patients with CES-II (L. Edelmann,
unpublished data). These results suggest that increased
gene dosage could contribute to the etiology of the de-
velopmental delay in this patient. The patient’s mother
and grandmother have the same duplication but are phe-
notypically normal, suggesting variable penetrance and
a mild phenotype. Alternatively, the developmental delay
in this patient could have a different basis, independent
of the duplication of 22q11. To distinguish between
these two possibilities, it will be necessary to ascertain
additional patients with duplications of the 22q11 re-
gion who do not have other chromosomal abnormalities.
More than 20 genes and expressed sequences have
been isolated from the 1.5-Mb 22q11.2 region that is
shared by CES-II, der(22) syndrome, and VCFS/DGS.
One way to assess the role of increased or decreased
gene dosage in the etiology of congenital anomalies is
to generate mice with a similar deletion or duplication,
respectively, of the region of synteny in the mouse (Ra-
mirez-Solis et al. 1995; Smith et al. 1995; Van Deursen
et al. 1995). The 1.5-Mb region on the 22q11 region is
conserved, and it maps to mouse chromosome 16 (Puech
et al. 1997). On the basis of the high level of conser-
vation between mice and humans, it may be possible to
generate nested deletions and duplications that span the
entire interval of overlap between the two disorders. By
means of this approach, the molecular basis of VCFS,
as well as the contributions of the deleted region to
der(22) syndrome and CES, can be determined precisely.
Acknowledgments
We thank Drs. Raju Kucherlapati, Arthur Skoultchi, Anne
Puech, and Bruno Saint-Jore for their helpful discussions. We
would like to thank Dr. Ellen Magenis for her helpful discus-
sions of the patient with the duplication (see Discussion). This
work was supported by National Institutes of Health (NIH)
grant PO-1 HD34980-01 (to B.E.M.). This work was also
supported by a National Alliance for Research in Schizophre-
nia and Depression award (1996–98), an American Heart As-
sociation grant-in-aid, an American Heart Association Inves-
tigatorship Award, and March of Dimes grant FY98-0414 (to
B.E.M). L.E. is supported by NIH grant T32 CA09060. B.E.M.
is supported, in part, by Deutsche Forschungsgemeinschaft.
Electronic-Database Information
Accession numbers and URLs for data in this article are as
follows:
Coriell Cell Repositories, NIGMS cell repository, http://
arginine.umdnj.edu/ccr.html (for cell lines from two patients
[GM06228 and GM04370] with der[22] syndrome)
GenBank, http://www.ncbi.nlm.nih.gov/Web/Genbank (for the
Funke et al.: Der(22) Syndrome and VCFS 757
phosphatidylinositol 4–kinase gene [AF012872] and for
ADU6 and ADU1 [AC000095])
Online Mendelian Inheritance in Man (OMIM), http://
www.ncbi.nlm.nih.gov/Omim (for CES [MIM 115470],
VCFS [MIM 192430], and DGS [MIM 188400])
University of Oklahoma, map of DiGeorge region of human
chromosome 22 and syntenic mouse chromosome 16, http:
//www.genome.ou.edu/maps/dgcr.html
References
Aubry M, Demczuk S, Desmaze C, Aikem M, Aurias A, Julien
JP, Rouleau GA (1993) Isolation of a zinc finger gene con-
sistently deleted in DiGeorge syndrome. Hum Mol Genet 2:
1583–1587
Baumer A, Dutly F, Balmer D, Riegel M, Tukel T, Krajewska-
Walasek M, Schinzel AA (1998) High level of unequal mei-
otic crossovers at the origin of the 22q11.2 and 7q11.23
deletions. Hum Mol Genet 7:887–894
Bischoff FR, Krebber H, Smirnova E, Dong W, Ponstingl H
(1995) Co-activation of RanGTPase and inhibition of GTP
dissociation by Ran-GTP binding protein RanBP1. EMBO
J 15:705–715
Budarf ML, Collins J, Gong W, Roe B, Wang Z, Bailey LC,
Sellinger B, et al (1995) Cloning a balanced translocation
associated with DiGeorge syndrome and identification of a
disrupted candidate gene. Nat Genet 10:269–278
Budarf ML, Eckman B, Michaud D, McDonald T, Gavigan S,
Buetow KH, Tatsumura Y, et al (1996) Regional localization
of over 300 loci on human chromosome 22 using a somatic
cell hybrid mapping panel. Genomics 35:275–288
Carey AH, Roach S, Williamson R, Dumanski JP, Norden-
skjold M, Collins VP, Rouleau G, et al (1990) Localization
of 27 DNA markers to the region of human chromosome
22q11-pter deleted in patients with the DiGeorge syndrome
and duplicated in the der22 syndrome. Genomics 7:299–306
Carlson C, Sirotkin H, Pandita R, Goldberg R, McKie J,
Wadey R, Patanjali SR, et al (1997) Molecular definition of
22q11 deletions in 151 velo-cardio-facial syndrome patients.
Am J Hum Genet 61:620–629
Chance PF, Abbas N, Lensch MW, Pentao L, Roa BB, Patel
PI, Lupski JR (1994) Two autosomal dominant neuropathies
result from reciprocal DNA duplication/deletion of a region
on chromosome 17. Hum Mol Genet 3:223–228
Chen KS, Manian P, Koeuth T, Potocki L, Zhao Q, Chinault
AC, Lee CC, et al (1997) Homologous recombination of a
flanking repeat gene cluster is a mechanism for a common
contiguous gene deletion syndrome. Nat Genet 17:154–163
Collins J, Cole C, Smink L, Garret C, Leversham M, Sodeer-
lund C, Maslen G, et al (1995) A high density contig map
of human chromosome 22. Nature 337:367–379
Collins JE, Mungall AJ, Badcock KL, Fay JM, Dunham I
(1997) The organization of the gamma-glutamyl transferase
genes and other low copy repeats in human chromosome
22q11. Genome Res 7:522–531
Di Matteo G, Salerno M, Guarguaglini G, Di Fiore B, Palitti
F, Lavia P (1998) Interactions with single-stranded and dou-
ble-stranded DNA-binding factors and alternative promoter
conformation upon transcriptional activation of the Htf9-
a/RanBP1 and Htf9-c genes. J Biol Chem 273:495–505
DiGeorge A (1965) A new concept of the cellular basis of
immunity. J Pediatr 67:907–908
Driscoll DA, Budarf ML, Emanuel BS (1992a) A genetic eti-
ology for DiGeorge syndrome: consistent deletions and mi-
crodeletions of 22q11. Am J Hum Genet 50:924–933
Driscoll DA, Spinner NB, Budarf ML, McDonald-McGinn
DM, Zackai EH, Goldberg RB, Shprintzen RJ, et al (1992b)
Deletions and microdeletions of 22q11.2 in velo-cardio-fa-
cial syndrome. Am J Med Genet 44:261–268
Edelmann L, Pandita RK Morrow B. Low copy repeats mediate
the common 3-Mb deletion in patients with velo-cardio-
facial syndrome. Am J Hum Genet (in press)
Fraccaro M, Lindsten J, Ford CE, Iselius L (1980) The 11q;22q
translocation: a European collaborative analysis of 43 cases.
Hum Genet 56:21–51
Guanti G (1981) The aetiology of the cat eye syndrome re-
considered. J Med Genet 18:108–118
Halford S, Lindsay E, Nayudu M, Carey AH, Baldini A, Scam-
bler PJ (1993a) Low-copy-number repeat sequences flank
the DiGeorge/velo-cardio-facial syndrome loci at 22q11.
Hum Mol Genet 2:191–196
Halford S, Wilson DI, Daw SC, Roberts C, Wadey R, Kamath
S, Wickremasinghe A, et al (1993b) Isolation of a gene ex-
pressed during early embryogenesis from the region of
22q11 commonly deleted in DiGeorge syndrome. Hum Mol
Genet 2:1577–1582
Herzog R, Lutz S, Blin N, Marasa JC, Blinder MA, Tollefsen
DM (1991) Complete nucleotide sequence of the gene for
human heparin cofactor II and mapping to chromosomal
band 22q11. Biochemistry 30:1350–1357
Knoll JHM, Asamoah A, Pletcher BA, Wagstaff J (1995) In-
terstitial duplication of proximal 22q: phenotypic overlap
with cat eye syndrome. Am J Med Genet 55:221–224
Kurahashi H, Nakayama T, Osugi Y, Tsuda E, Masuno M,
Imaizumi K, Kamiya T, et al (1996) Deletion mapping of
22q11 in CATCH22 syndrome: identification of a second
critical region. Am J Hum Genet 58:1377–1381
Levy A, Demczuk S, Aurias A, Depetris D, Mattei M, Philip
N (1995) Interstitial 22q11 microdeletion excluding the
ADU breakpoint in a patient with DiGeorge syndrome. Hum
Mol Genet 4:2417–2419
Lin AE, Bernar J, Chin AJ, Sparkes RS, Emanuel BS, Zackai
EH (1986) Congenital heart disease in supernumerary
der(22), t(11;22) syndrome. Clin Genet 29:269–275
Lindsay EA, Goldberg R, Jurecic V, Morrow B, Carlson C,
Kucherlapati RS, Shprintzen RJ, et al (1995) Velo-cardio-
facial syndrome: frequency and extent of 22q11 deletions.
Am J Med Genet 57:514–522
Lindsay EA, Halford S, Wadey R, Scambler PJ, Baldini A
(1993) Molecular cytogenetic characterization of the Di-
George syndrome region using fluorescence in situ hybrid-
ization. Genomics 17:403–407
Luan X, Shi G, Zohouri M, Paradee W, Smith DI, Decker HJ,
Cannizzaro LA (1997) The FHIT gene is alternatively spliced
in normal kidney and renal cell carcinoma. Oncogene 15:
79–86
McTaggart KE, Budarf ML, Driscoll DA, Emanuel BS, Ferreira
P, McDermid HE (1998) Cat eye syndrome chromosome
breakpoint clustering: identification of two intervals also
758 Am. J. Hum. Genet. 64:747–758, 1999
associated with 22q11 deletion syndrome breakpoints. Cy-
togenet Cell Genet 81:222–228
Mears AJ, Duncan AMV, Budarf ML, Emanuel BS, Sellinger
B, Siegel-Bartelt J, Greenberg CR, et al (1994) Molecular
characterization of the marker chromosome associated with
cat eye syndrome. Am J Hum Genet 55:134–142
Mears AJ, el-Shanti H, Murray JC, McDermid HE, Patil SR
(1995) Minute supernumerary ring chromosome 22 asso-
ciated with cat eye syndrome: further delineation of the crit-
ical region. Am J Hum Genet 57:667–673
Morrow B, Goldberg R, Carlson C, Das Gupta R, Sirotkin H,
Collins J, Dunham I, et al (1995) Molecular definition of
the 22q11 deletions in velo-cardio-facial syndrome. Am J
Hum Genet 56:1391–1403
Moyzis RK, Torney DC, Meyne J, Buckingham JM, Wu JR,
Burks C, Sirotkin KM, et al (1989) The distribution of in-
terspersed repetitive DNA sequences in the human genome.
Genomics 4:273–289
O’Donnell H, McKeown C, Gould C, Morrow B, Scambler P
(1997) Detection of an atypical 22q11 deletion that has no
overlap with the DiGeorge syndrome critical region. Am J
Hum Genet 60:1544–1548
Perez Jurado LA, Wang YK, Peoples R, Coloma A, Cruces J,
Francke U (1998) A duplicated gene in the breakpoint
regions of the 7q11.23 Williams-Beuren syndrome deletion
encodes the initiator binding protein TFII-I and BAP-135,
a phosphorylation target of BTK. Hum Mol Genet 7:
325–334
Prasher VP, Roberts E, Norman A, Butler AC, Krishnan VH,
McMullan DJ (1995) Partial trisomy 22 (q11.2-q13.1) as a
result of duplication and pericentric inversion. J Med Genet
32:306–308
Puech A, Saint-Jore B, Funke B, Gilbert DJ, Sirotkin H, Cope-
land NG, Jenkins NA, et al (1997) Comparative mapping
of the human 22q11 chromosomal region and the orthol-
ogous region in mice reveals complex changes in gene or-
ganization. Proc Natl Acad Sci USA 94:14608–14613
Ramirez-Solis R, Liu P, Bradley A (1995) Chromosome engi-
neering in mice. Nature 378:720–724
Reiss JA, Weleber RG, Brown MG, Bangs CD, Lovrien EW,
Magenis RE (1985) Tandem duplication of proximal 22q:
a cause of cat-eye syndrome. Am J Med Genet 20:165–171
Scambler PJ, Kelly D, Lindsay E, Williamson R, Goldberg R,
Shprintzen R, Wilson DI, et al (1992) Velo-cardio-facial syn-
drome associated with chromosome 22 deletions encom-
passing the DiGeorge locus. Lancet 339:1138–1139
Schinzel A, Schmid W, Fraccaro M, Tiepolo L, Zuffardi O,
Opitz JM, Lindsten J, et al (1981) The “cat eye syndrome”:
dicentric small marker chromosome probably derived from
a no. 22 (tetrasomy 22pter to q11) associated with a char-
acteristic phenotype. Hum Genet 57:148–158
Shprintzen RJ, Goldberg RB, Lewin ML, Sidoti EJ, Berkman
MD, Argamaso RV, Young D (1978) A new syndrome in-
volving cleft palate, cardiac anomalies, typical facies, and
learning disabilities: velo-cardio-facial syndrome. Cleft Pal-
ate J 15:56–62
Smeets D, van Ravenswaaij C, de Pater J, Gerssen-Schoorl K,
Van Hemel J, Janssen G, Smits A (1997) At least nine cases
of trisomy 11q23rqter in one generation as a result of fa-
milial t(11;13) translocation. J Med Genet 34:18–23
Smith AJ, De Sousa MA, Kwabi-Addo B, Heppell-Parton A,
Impey H, Rabbitts P (1995) A site-directed chromosomal
translocation induced in embryonic stem cells by Cre-loxP
recombination. Nat Genet 9:376–385
Van Deursen J, Fornerod M, Van Rees B, Grosveld G (1995)
Cre-mediated site-specific translocation between nonho-
mologous mouse chromosomes. Proc Natl Acad Sci USA 92:
7376–7380
Van Hove JLK, McConkie-Rosell A, Chen Y-T, Iafolla
AK, Lanman JT Jr, Hennessy MD, Kahler SG (1992) Unbal-
anced translocation 46,XY,15,der(22)t(15;22)(q13;q11)
pat: case report and review of the literature. Am J Med Genet
44:24–30
Wandstrat AE, Leana-Cox J, Jenkins L, Schwartz S (1998)
Molecular cytogenetic evidence for a common breakpoint
in the largest inverted duplications of chromosome 15. Am
J Hum Genet 62:925–936
Zackai EH, Emanuel BS (1980) Site-specific reciprocal trans-
location t(11;22)(q23;q11), in several unrelated families
with 3:1 meiotic disjunction. Am J Med Genet 7:507–521
